Morphine
CLINICAL USE
Opiate analgesic
DOSE IN NORMAL RENAL FUNCTION
5–20 mg every 4 hours (higher in very severe pain or terminal illness)PR: 15–30 mg every 4 hours
PHARMACOKINETICS
Molecular weight                           :285.3 (758.8 as sulphate); (774.8 as tartrate) %Protein binding                           :20–35 %Excreted unchanged in urine     : 10 Volume of distribution (L/kg)       :3–5half-life – normal/ESRD (hrs)      :2–3/Unchanged DOSE IN RENAL IMPAIRMENT
GFR (mL/MIN)
20 to 50     : 75% of normal dose 10 to 20     : Use small doses, e.g. 2.5–5 mg and extended dosing intervals. Titrate according to response <10           : Use small doses, e.g. 1.25–2.5 mg and extended dosing intervals. Titrate according to response DOSE IN PATIENTS UNDERGOING RENAL REPLACEMENT THERAPIES
CAPD                :Not dialysed. Dose as in GFR <10 mL/min HD                     :Dialysed – active metabolite removed significantly. Dose as in GFR <10 mL/minHDF/high flux   :Dialysed – active metabolite removed significantly. Dose as in GFR <10 mL/minCAV/VVHD      :Dialysed. Dose as in GFR=10–20 mL/min IMPORTANT DRUG INTERACTIONS
Potentially hazardous interactions with other drugsAntidepressants: possible CNS excitation or depression with MAOIs – avoid concomitant use, and for 2 weeks after stopping MAOI; possible CNS excitation or depression with moclobemide; increased sedative effects with tricyclicsAntivirals: concentration possibly increased by ritonavirSodium oxybate: enhanced effect of sodium oxybate – avoid concomitant use ADMINISTRATION
Reconstition
– Route
Oral, SC, IM, IV, PR Rate of Administration
2 mg/minute. (Titrate according to response)Comments
– OTHER INFORMATION
Extreme caution with all opiates in patients with impaired renal functionPotential accumulation of morphine-6- glucuronide (a renally excreted active metabolite, more potent than morphine) and morphine-3-glucuronide. Half-life of morphine-6-glucuronide is increased from 3–5 hours in normal renal function to about 50 hours in ERFENSURE NALOXONE READILY AVAILABLESome units avoid slow release oral preparations as any side effects may be prolonged.
See how to identify renal failure stages according to GFR calculation
See how to diagnose irreversible renal disease
Home